News
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...
FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...
There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...
Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.
Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...
The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...
FDA announced the launch of Elsa, a generative artificial intelligence (AI) tool designed to help employees from scientific ...
An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to ...
Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
A new FDA artificial intelligence tool designed to streamline medical device reviews is faltering in its early rollout stages, raising concerns for agency staff and ethics experts about its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results